Background/Aims: Thymic stromal lymphopoietin (TSLP) is a cytokine that plays diverse roles in the regulation of immune responses. However, a detailed understanding of the TSLP signaling pathway in asthma remains elusive. In this study, we aimed to investigate the role of the TSLP signaling pathway in asthma and its effect on airway inflammation and remodeling. Methods: Forty Sprague Dawley (SD) rats were evenly classified into control, asthma, IgG2a mAb and anti-TSLP mAb groups. Ovalbumin (OVA)-induced asthma models were successfully established. Blood, bronchoalveolar lavage fluid (BALF) and lung tissue samples were prepared. Total BALF leukocytes were counted, and the proportions of different leukocyte types were determined. Reverse transcription quantitative polymerase chain reaction (RTqPCR) and immunohistochemistry were performed to determine the mRNA and protein levels of TSLP, OX40L, α-smooth muscle actin (α-SMA, a marker of airway remodeling in asthma) and collagen I in the plasma. Enzyme-linked immunosorbent assay (ELISA) was carried out to measure the concentrations of TSLP, OX40L, and other inflammatory factors, such as interferon (IFN)-γ, interleukin (IL)-4, IL-5 and IL-13, in the plasma. Results: Compared with the control group, there were more leukocytes, increased EOS and LYM proportions, higher Underwood and PAS scores, increased WT t , WT m , WA t /A 0 , WA m /WA t , WT t /R 0 , WT m /WT t , TSLP, OX40L, a-SMA and collagen I mRNA and protein levels, and higher SLP, OX40L, IL-4, IL-5 and IL-13 levels, but lower MON proportions and IFN-γ levels in the asthma and IgG2a mAb groups. Compared with the asthma and IgG2a mAb groups, there were less leukocytes, decreased EOS and LYM proportions, lower Underwood and PAS scores, decreased WT t , WT m , WA t /A 0 , WA m /WA t , WT t / R 0 , WT m /WT t , TSLP, OX40L, a-SMA and Collagen I mRNA and protein levels, and lower levels of SLP, OX40L, IL-4, IL-5 and IL-13, but higher MON proportions and IFN-γ levels in the anti-TSLP mAb group. WT m and WT t were positively associated with the TSLP, OX40L, α-SMA and
Introduction
Asthma, which is known as a complex chronic inflammatory disease, affects over 500 million people worldwide, and its prevalence is increasing, representing the second most common chronic inflammatory disease of the lower airways [1, 2] . The recurrent episodic symptoms of this disease include tightness of the chest, wheezing, coughing and shortness of breath [3] . A study showed that increased mucus accumulation can result in airway obstruction in asthmatic patients [4] . In addition to mucus hypersecretion, the pathological characteristics of asthma also involve infiltration of the airway by eosinophils, mast cells, and lymphocytes, and persistent changes to the normal airway structure, such as subepithelial fibrosis, goblet cell hyperplasia, thickening of bronchial walls, and hypertrophy/hyperplasia of airway smooth muscle [5, 6] .
Airway inflammation, remodeling and hyperresponsiveness are also characterized in clinical asthmatic patients [7] . Airway remodeling is arguably one of the most refractory problems for asthma patients, resulting in irreversible loss of lung function [8, 9] . Asthma patients require treatment with long-acting beta agonists, inhaled corticosteroids or leukotrienes (modifier/theophylline) for prevention against symptoms becoming "uncontrolled" or disease that remains "uncontrolled" despite this treatment [10] . Despite several investigations of airway inflammation and remodeling in asthma, its pathogenesis and the effects of current asthma therapies on remodeled and inflammatory airways still needs clarification.
Thymic stromal lymphopoietin (TSLP), a newly identified interleukin-7-like cytokine, was originally isolated from a murine thymic stromal cell line and plays an essential role in T helper 2 (Th2) cell-mediated allergic inflammation [11, 12] . Airway inflammation in asthma may result from Th2 lymphocyte cytokine secretion (involving interleukin [IL]-4, IL-5 and IL-13) that contributes to cellular inflammation [13] . Airway remodeling in asthma is often referred to as structural changes, which do great damage to airway smooth muscles, epithelium, blood vessels and bronchial walls [14] . It was reported that airway remodeling development involving subepithelial fibrosis and goblet cell hyperplasia is related to Th2 lymphocyte cytokine secretion induced by CD4+ T cells [15] . OX40 is a costimulatory receptor that is transiently expressed on activated T cells, and its ligand, OX40L, is expressed on a broad range of cell types, including dendritic, natural killer, vascular endothelial, mast and B cells [16] . The costimulatory molecule, OX40L, is critical for both Th1 and Th2 responses in allergic inflammation [17] . TSLP activates myeloid dendritic cells (DCs) to produce OX40L, which triggers the Th2 inflammatory response [18] . Therefore, the TSLP signaling pathway seems to be a significant factor in the development of airway inflammation and remodeling in asthma. However, little is known regarding the underlying mechanisms that regulate airway inflammation and remodeling in asthma. In this study, the effects of the TSLP signaling pathway on airway inflammation and remodeling were investigated in ovalbumin (OVA)-induced asthma rat models.
Materials and Methods

Ethics statement
All experiments and processes were performed with the approval of the Animal Care and Use Committee in the First Affiliated Hospital of Zhengzhou University. 
Animal grouping and model establishment
After being fed for a week for adaptation, the 40 rats were randomly and evenly assigned into control, asthma, anti-TSLP monoclonal antibody (mAb) treated (injected with anti-TSLP mAb) and IgG2a mAb treated groups. The model was established as follows: in the asthma group, 1 mg of freshly prepared ovalbumin (OVA) and 2 ml of fluid with aluminum hydroxide (100 mg) were intraperitoneally injected into the rats on the 1 st and 8 th days, respectively. During the 15 th day, asthma was stimulated with pulverized 1% OVA in normal saline by inhalation in a semi-closed box every two days (30 min each time). After the stimulation, the models were regarded as successfully established if the rats showed quicken respiration, cyanosis on the lips, burnout and weakness. For the control group, the rats were treated in the same way; however, they were intraperitoneally injected with normal saline followed by inhalation of pulverized normal saline. For the anti-TSLP mAb group, rats were treated in the same way as those in the asthma group; however, 3 h before the 6 th inhalation, the former were intranasally administered 50 µl of anti-TSLP mAb (1 μg/μl) for 5 successive days. For the IgG2a mAb group, the rats were treated in the same way as those in the anti-TSLP mAb group, except the former were treated with 50 µl of IgG2a mAb (1 μg/μl) for 5 successive days (Fig. 1) . The rats' health conditions were observed and recorded, including body weight, hair color, respiratory rate, activity, and responsiveness.
Tissue collection
Within 24 hours after the last OVA stimulation, blood samples were taken from the inferior vena cava of the rats after they were anesthetized with an intraperitoneal injection of 10% chloral hydrate (4 mg/kg). Their blood samples were centrifuged at 3, 000 rpm/min for 10 min, and serum was collected in different centrifuge tubes and preserved at -80°C. Then, bronchoalveolar lavage fluid (BALF) was prepared. Next, the rats' chests were opened, and their lung tissue was immediately observed for general changes. Then, their tracheas were cut and intubated with a scalp needle, a trachea cannula was fixed using silk thread, and their lung tissues were taken apart. The left main bronchus was ligated, and the left lungs were lavaged through the bronchus. The right lungs were washed with phosphate buffer solution (PBS) via three injections with a total of 8 ml. At the same time, the lung tissue was kneaded gently, and 30 s later, the BALF was obtained from the right lung, which was then centrifuged at 3, 000 rpm/min for 10 min. The supernatant was preserved at -80°C. The BALF sediment was re-suspended in PBS for sedimentary smears so that leukocyte counts could be obtained.
The lung tissue samples were prepared. Lung tissue (approximately 3 mm ×3 mm ×3 mm) was cut from the hilum of the right lungs (near the anterior lobe) using surgical scissors and forceps (RNAase was inactivated by high temperature). The lung tissues were fixed in 4% paraformaldehyde, followed by paraffin embedding. Another piece of lung tissue (approximately 1 mm × 1 mm × 1 mm) was cut from the hilum of the right lung (near anterior lobe), fixed in cold 2.5% glutaraldehyde solution for 5 min and then preserved at 4°C or observed under an electron microscope. Additional lung tissue samples were preserved in centrifuge tubes at -80°C
Total and differential BALF leukocyte counts Total BALF leukocyte numbers were counted. The BALF sediment was re-suspended in 1 ml PBS, which was dropped onto slides and dried. Then, 100 μL of cell resuspension solution was placed in a cell counting plate to count the total number of leukocytes under a low-powered microscope. Total leukocyte numbers were counted according to the following formula: leukocyte count/L = (Total leukocyte count in four squares × 10 9 )/20. Different leukocyte types were counted. BALF sediment was smeared onto slides, dried, and fixed with Wright's staining solution (2-4 drops) for 30-60 s. Then, a buffer solution (2-4 drops) was added to the slides, the slides were stained for 5-10 min, and the staining solution was washed with distilled water. Different fields of the smear junctions and tails (best-stained part) were observed under a high-powered microscope. According to the different morphological characteristics of the different leukocyte types, 100 leukocytes were counted. Eosinophils (EOS) are round or oval with large cell bodies and bright red granules in their cytoplasm after staining. Lymphocytes (LYM) vary in size, are round or oval, and have a cardinal color after being stained with a sunken side. Monocytes (MON) are identified by large cell bodies, irregular shape with a darker smoky-gray cytoplasm, purple-brown nucleus and loose reticular nuclear chromatin.
Hematoxylin-eosin (HE) staining
The lung tissues were fixed in 4% paraformaldehyde, embedded with paraffin and sliced to 4 μm thickness. Then, they were conventionally dehydrated with ethyl alcohol, cleared with xylene and embedded in paraffin to be make paraffin blocks. After being sliced, the blocks were placed in a 59°C oven to melt the paraffin, transparentized with xylene for 30 min, stained with hematoxylin for 10 min, differentiated with hydrochloric acid and washed with flowing water. Next, the slices were stained with eosin and dehydrated with alcohol. Once baked, the slices were sealed in resin. When the slices in each group were stained with HE, the slices were randomly selected for airway epithelium injury under a microscope (200 ×). Finally, eosinophil infiltration, edema and airway epithelium injury around the blood vessels and bronchi were evaluated according to the Underwood standard [19] . Table 1 shows more details.
PAS staining
The lung tissues were slices to 4 μm thickness, oxidized with 0.5% periodic acid for 5-10 min, and rinsed with flowing water. Then, the tissues were immersed in distilled water, stained with Schif's solution for 10-30 min at room temperature, and then rinsed with flowing water for 5 min with distilled water twice. After staining with Harris hematoxylin for 2-3 min, the tissues were rinsed with flowing water for 2 min, differentiated in 1% hydrochloric acid alcohol for 30 s (fast in and fast out), washed with flowing water for 5 min to make them blue and cleared by conventional dehydration. Finally, the slices were sealed in neutral balsam. Under an optical microscope, the proliferation and mucus secretion of the airway mucosa goblet cells were observed. The proportion of goblet airway epithelial cells was calculated, and scores were calculated based on the following standard: 0, < 5%; 1, 5 ~ 25%; 2, 25 ~ 50%; 3, 50 ~ 75%; 4, > 75%. The experiment was repeated three times for each group.
Type II alveolar epithelial cell identification under a transmission electron microscope
After the type II rat alveolar epithelial cells were isolated, they were mixed into suspension and filtered. Then, the filtered fluid was centrifuged and re-suspended with 10 ml of Dulbecco's modified eagle medium (DMEM) with fetal bovine serum, 100 U/ml penicillin and 100 U/ml streptomycin. After the cell concentration was adjusted to 3×10 6 cells/ml, the cells were inoculated into 6-well plates for future experiments. The differentiated and purified type II rat alveolar epithelial cells were re-suspended and centrifuged, and the sediment was fixed in 2.5% glutaraldehyde, rinsed with PBS, dehydrated with acetone, fixed with 1% osmium tetroxide, embedded with epoxy resin and stained with lead citrate. Finally, the cells were observed under a transmission electron microscope.
Analysis of airway morphological parameters under a light microscope
Image-Pro Plus software (Media Cybernetics, Inc., Maryland, USA) was used to analyze the total bronchial wall area (WA t ), bronchial smooth muscle area (WA m ), bronchial wall thickness (WT t ), bronchial smooth muscle thickness (WT m ), the ratio of WAt to the total area of the bronchus (WA t /A 0 ), the WAm to WAt ratio (WA m /WA t ), the WTt to bronchial thickness ratio (WT t /R 0 ) and the WTm to WTt ratio (WT m /WT t ). The specific procedures were as follows: under a light microscope (× 400), 2-5 complete middle or small bronchi were selected in each rat, and a pathologic image analysis system was applied to collect and measure the bronchial basement membrane perimeter (Pb m ), bronchial perimeter (P 0 ), total bronchus area (A 0 ), lumen area (A i ), trachea area in the outer smooth muscle (A mo ) and trachea area in the inner smooth muscle (Ami). 
Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
The TSLP, OX40L, α-smooth muscle actin (α-SMA, a marker of airway remodeling in asthma) and collagen I mRNA levels in the lungs were detected by RT-qPCR. Total RNA was extracted from the lung tissue with Trizol® reagent and preserved at -80°C. Total RNA was reverse transcribed to complementary DNA (cDNA) using the PrimeScript™ RT reagent kit (Takara Biotechnology Ltd., Dalian, China), which was then preserved at -20°C. RT-qPCR was carried out using an Applied Biosystems 7500 RT-PCR System (Applied Biosystems, Inc., CA, USA). The primer sequences were designed by Shanghai Kehua Bio-engineering Co., Ltd, Shanghai, China (Table 2 ). For the RT-PCR of TSLP and OX40L cDNA, the conditions were as follows: pre-denaturation at 95°C for 30 s, 40 cycles of denaturation at 95°C for 5 s, and annealing and extension at 59°C for 30 s. For the RT-PCR of α-SMA cDNA, the conditions were as follows: pre-denaturation at 95°C or 30 s, 40 cycles of denaturation at 95°C for 5 s, and annealing and extension at 72°C for 30 s. For type I collagen, the conditions were as follows: pre-denaturation at 95°C for 30 s, 40 cycles of denaturation at 95°C for 5 s, and annealing and 
Immunohistochemistry
The TSLP, OX40L, α-SMA and collagen I protein levels in the lung tissues were detected by immunohistochemistry. APC-A-labeled goat anti-mouse IgG 2α served as an isotype control. PBS served as a negative control of the primary antibody. The lung tissue sections were stained with Histostain TM SP-9000 (Zymed Laboratories Inc., CA, USA). After being routinely dewaxed to water, the sections were heated for antigen retrieval using a microwave, which was terminated when the samples started boiling. Five min later, the sections were heated again, and then they were cooled to room temperature. Then, the sections were washed with PBS, blocked with normal goat serum and primary antibodies were added (rabbit antimouse TSLP polyclonal antibody, rabbit anti-mouse OX40L polyclonal antibody, rabbit anti-mouse α-SMA polyclonal antibody, rabbit anti-mouse collagen I polyclonal antibody, Abcam Inc., Cambridge, MA, USA) and preserved at 4°C overnight. The slides were reheated to 37°C, washed with PBS, and then secondary antibody in a working solution was added (biotin-conjugated goat anti-rabbit IgG and goat anti-mouse IgG) and preserved at 37°C for 30 min. After washing with PBS, the lung tissue sections were incubated with horseradish peroxidase-labeled working fluid, and 3, 3-diaminobenzidine (DAB, chromogenic agent) was added for color development for 5-10 min. The staining duration was adjusted under a microscope, and after being re-stained with hematoxylin, the sections were sealed with neutral balsam. After being baked, the sections were photographed.
Cells with brownish yellow nuclear or cytoplasm were regarded as positive cells. Image-Pro Plus software was used to analyze the protein expression. For each protein, 3 sections were detected, and for each section, the integrated optical density (IOD) of 5 random fields was evaluated to obtain a mean value.
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of TSLP, OX40L, and inflammatory factors, such as interferon (IFN)-γ, interleukin (IL)-4, IL-5 and IL-13 in the plasma were detected. The ELISA plates were proportionately diluted, step by step. Eight standard wells were set with a volume of 100 μL each, together with blank and sample wells. Sample diluent (40 μL) and samples (10 μL) were added into the wells and gently mixed with each other (while not touching the plate walls). The plates were incubated at 37°C for 120 min, washed with washing solution 4-5 times and dried on filter paper. A primary antibody working solution (50 μl) was added into each well, mixed with plasma and incubated at 37°C for 60 min. Then, the plates were washed again, and 100 μL of enzyme-labeled antibody was added to each well. The plates were incubated at 37°C for 120 min and then washed. One hundred microliters of chromogenic substrate was added to each well and preserved at 37°C without light for 10-15 min for reaction, which was terminated by adding 50 μl of stop buffer into each well. Optical densities (OD) at 492 nm were recorded using an ELISA reader. The OD values of the samples were plotted on semi-logarithmic paper to obtain standard curves. A zero adjustment (the OD value of the sample minus the OD value of the blank) was performed. The TSLP, OX40L, IFN-γ, IL-4, IL-5 and IL-13 concentrations in the plasma were converted by the standard curve formula in accordance with the OD values of the samples.
Statistical analysis
Data were processed using SPSS 21.0 software and presented as mean ± standard deviation (SD). Comparisons of the measurement data that were normally distributed between the samples were verified by t-test and paired t-test. Differences among the groups were analyzed by one-way analysis of variance (ANOVA). If the variance was not homogeneous, differences were assessed with the Welch approximate-t test. Comparisons among multiple groups were assessed with Dunnett's T3 test. Measurement data are expressed as percentages and rates and verified with the chi-square test. Correlations were analyzed with the Pearson's test. P < 0.05 was regarded statistically significant.
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Results
Ovalbumin (OVA)-induced asthma models are successfully established
The rats in each group were observed to determine their general conditions, which included status, hair, respiration, cyanosis, irritability, restlessness and diet evaluations. The control group rats were active and agile and had smooth hair and ate normally. The asthma and IgG2a mAb group rats they exhibited allergic symptoms after OVA inhalation, including restlessness, scratching, limb licking and sneezing, and as time went on, they had faster respiration rates and dyspnea (obvious abdominal respiration) with slight cyanosis. Most of the asthma and IgG2a mAb group rats had obvious expiratory sounds and irregular inspiration. For the anti-TSLP mAb group rats, the abovementioned symptoms were reversed, and they ate and breathed normally and had smoother hair and better statuses. The body weights in each group were time-correlated and increased over time (P < 0.05). However, there were no body weight differences among the rats of the same group (P> 0.05) ( Table 3) .
Comparison of total and differential leukocyte levels among the control, asthma, IgG2a mAb and anti-TSLP mAb groups
BALF smears were observed for cellular morphology, and the results showed that in the control and anti-TSLP mAb groups, most the BALF cells were monocyte, with few eosinophils. For the asthma and IgG2a mAb groups, many more eosinophils were observed than in the control and anti-TSLP mAb groups (Fig. 2) . The total and sub-type cell numbers in the BALF were statistically analyzed. Compared with the control group, there were more leukocytes, increased EOS and LYM proportions, and decreased MON proportions in the asthma and IgG2a mAb groups (all P < 0.05), whereas no differences existed between the control and the anti-TSLP mAb groups (all P > 0.05). Compared with the asthma and IgG2a mAb groups, there were less leukocytes, decreased EOS and LYM proportions, and increased MON proportions in the anti-TSLP mAb groups (all P < 0.05). However, no differences between the asthma and IgG2a mAb groups were observed (all P > 0.05) ( Table 4) .
Pathologic lung tissue changes among the control, asthma, IgG2a mAb and anti-TSLP mAb groups
After HE staining, cellular morphology was observed. The lung tissues in the control and anti-TSLP mAb groups had clear structures, fine epithelium mucosae and bronchial lumen and almost no inflammatory cell infiltration around blood vessels and the bronchus, together with no vascular smooth muscle hypertrophy and little secretion. For the asthma and IgG2amAb group rats, there was a large amount of inflammatory cell infiltration, submucosal edema, increased mucosa folds, defective airway epithelial cells, epithelial cell exfoliation, thickened bronchial walls and basilar membrane, larger bronchial smooth muscles and narrower lumen. According to the statistical analysis, compared with the control group, the asthma and IgG2a mAb groups had higher Underwood scores (both P < 0.05), while the anti-TSLP mAb group was not different (P > 0.05). However, there were lower Underwood scores in the anti-TSLP mAb group than in the asthma and IgG2a mAb groups (all P < 0.05), with no differences between the asthma group and the IgG2a mAb groups (P > 0.05) (Fig.  3) . According to the PAS staining results, there was no goblet cell hyperplasia in the airway epithelium between the control and the anti-TSLP mAb groups, while the asthma and IgG2a mAb groups had remarkable goblet cell hyperplasia and mucus secretion. Compared with the control group, there were higher PAS scores in the asthma and IgG2a mAb groups (all P < 0.05), while no difference was seen between the control and the anti-TSLP mAb groups (both P > 0.05). Furthermore, the anti-TSLP mAb group had lower PAS scores than the asthma and the IgG2a mAb groups (both P < 0.05), and there was no significant difference between the asthma and IgG2a mAb groups (both P > 0.05) (Fig. 3B) .
Type II alveolar epithelial cell morphology changes among the control, asthma, IgG2a mAb and anti-TSLP mAb groups
Under a transmission electron microscope, the type II alveolar epithelial cells in the control and the anti-TSLP mAb groups were round or cubic, with thick or thin and long or short microvilli on the dissociative side. Additionally, they exhibited obvious nuclei, high electron densities, mitochondria, rough endoplasmic reticulum, Golgi apparatuses in the cytoplasm, and specific lamellar bodes. However, for the type II alveolar epithelial cells in the asthma and IgG2a mAb group, there was cellular degeneration, irregular morphology, little or no microvilli on the cell surface, disrupted cell membranes, condensed nuclei, less apparent organelles, empty or defective lamellar bodies and more vacuoles (Fig. 4) . Fig. 4 . Type II alveolar epithelial cell observations under a transmission electron microscope among the control, asthma, IgG2a mAb, and anti-TSLP mAb groups. Arrow 1 points to microvilli, arrow 2 points to lamellar bodies and arrow 3 points to mitochondria; TSLP, thymic stromal lymphopoietin. 
Airway morphology parameters among the control, asthma, IgG2a mAb and anti-TSLP mAb groups
Compared with the control group, there were increased WT t , WT m , WA t /A 0 , WA m /WA t , WT t /R 0 and WT m /WT t levels in the asthma and IgG2a mAb groups (all P < 0.05). Additionally, there were no differences between the anti-TSLP mAb and control groups (all P > 0.05). Compared with the asthma and IgG2a mAb groups, the anti-TSLP mAb group exhibited decreased WT t , WT m , WA t /A 0 , WA m /WA t , WT t /R 0 and WT m /WT t levels (all P < 0.05), while no differences were found between the asthma and IgG2a mAb groups (all P > 0.05) (Fig. 5) .
TSLP downregulation decreases the OX40L, α-SMA, and collagen I levels Immunohistochemistry and RT-qPCR were used to determine the TSLP, OX40L, α-SMA and collagen I protein and mRNA levels. There were higher TSLP, OX40L, α-SMA and collagen I protein and mRNA levels in the asthma and the IgG2a mAb groups compared with the control group (all P < 0.05), while there were no significant differences between the anti-TSLP mAb and the control groups (all P > 0.05). Compared with the asthma and IgG2a mAb groups, the anti-TSLP mAb group had decreased TSLP, OX40L, α-SMA and collagen I protein and mRNA levels (all P < 0.05), and the asthma group was not different from the IgG2a mAb group (all P > 0.05) (Fig. 6 ).
WTm and WTt positively correlate with TSLP, OX40L, α-SMA and, collagen I levels in the bronchus
According to the Pearson correlation analysis, WT m was positively correlated with TSLP, OX40L, α-SMA and collagen-I protein levels (r = 0.4929, r = 0.3633, r = 0.4079, r = 0.5484, respectively, n = 30, P < 0.05) (Fig. 7A) . Additionally, WT t was positively related with TSLP, OX40L, α-SMA and collagen-I protein levels (r = 0.3885, r = 0.4865, r = 0.4006, r = 0.4795, respectively, n = 30, P < 0.05) (Fig. 7B) . 6 . TSLP, OX40L, α-SMA, and collagen I levels in lung tissues among the control, asthma, IgG2a mAb, and anti-TSLP mAb groups. A, TSLP, OX40L, a-SMA, and collagen I levels using immunohistochemistry; B, TSLP, OX40L, a-SMA, and collagen I IOD values; C, TSLP, OX40L, a-SMA, and collagen I mRNA levels; *, P<0.05 compared with the control group; #, P<0.05 compared with the asthma group; ▲, P<0.05 compared with the IgG2a mAb group; IOD, integrated optical density; TSLP, thymic stromal lymphopoietin; α-SMA, α-smooth muscle actin. (IFN-γ, IL-4 , IL-5 and IL-13). Compared with the control group, there were increased TSLP, OX40L, IL-4, IL-5 and IL-13 expression levels and decreased IFN-γ expression levels in the asthma and the IgG2a mAb groups (all P < 0.05). There were no differences between the anti-TSLP mAb and control groups (all P > 0.05). In comparison with the asthma and IgG2a mAb groups, the IgG2a mAb group had decreased TSLP, OX40L, IL-4, IL-5 and IL-13 levels and increased IFN-γ levels (all P < 0.05). No differences existed between the asthma and IgG2a mAb groups (all P > 0.05) ( Table 5) .
Discussion
Asthma is a prevalent respiratory disorder resulting from chronic environmental aeroantigen exposure that includes airway remodeling (structural changes) and airway inflammation symptoms [20] . According to previous research studies, the TSLP signaling pathway appears to be an essential factor in airway inflammation and remodeling in asthma [11, 13, 15] . However, the effects of the TSLP signaling pathway on airway inflammation and remodeling that correlate with chronic allergen-induced asthma is still poorly understood. In the present study, we explored the effects of the TSLP signaling pathway on airway inflammation and airway structural changes in an OVA-induced asthmatic rat model. In this rat model, we found that the TSLP signaling pathway was markedly up-regulated in the airway of asthmatic rats and inhibition of the TSLP signaling pathway attenuated airway inflammation and structural remodeling in asthmatic rat models.
TSLP is a four-helix bundle cytokine that plays a key role in regulating immune responses and hematopoietic cell differentiation [21] . For airway inflammation initiation, TSLP was demonstrated to be an important factor through contacting lung dendritic cells (DCs) [22] . OX40L was proven to be a TSLP-induced surface marker on DCs that mediates Th2 lymphocyte cytokine secretion [23] . Airway inflammation and airway structural remodeling has been attributed to cytokines secreted by Th2 lymphocytes [24] . In a study by Lei et al, OX40 and OX40L levels were up-regulated in a rat asthmatic model. The up-regulation of OX40/OX40L signals could induce T cell proliferation and cytokine secretion in asthmatic 
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Cellular Physiology and Biochemistry mice, indicating that OX40L was involved in the pathogenesis of asthma [25] . This confirms the result of the present study that TSLP and OX40L were highly expressed in the airways of asthmatic rats.
Our data indicate that the BALF leukocyte numbers in both the asthma and IgG2a mAb groups were elevated compared with the control group. This may be due to the influence of varied administrations in the lung by continuous stimulation of foreign substances, including normal saline or anesthetic agents [20] . Transforming growth factor β1 expressed by eosinophils in the airway is known to result in the remodeling response by promoting structural changes [26] [27] [28] . Moreover, lymphocytes play a significant role in airway inflammation [29] . We also found that the bronchial wall and smooth muscle thicknesses were increased in the asthma and IgG2a mAb groups. These results indicated that the bronchial wall and smooth muscle thicknesses were increased in asthmatic rats. According to a previous study, airway remodeling affects airway smooth muscle, epithelium, blood vessels and bronchial walls [14] .
According to the ELISA results, the TSLP, OX40L, a-SMA, Collagen I, IL-4, IL-5 and IL-13 levels in the plasma were significantly decreased; however, the IFN-γ levels were increased in the anti-TSLP group when compared with those in the asthma and IgG2a mAb groups. This demonstrated that TSLP pathway inhibition could down-regulate TSLP, OX40L, a-SMA, Collagen I, IL-4, IL-5 and IL-13 levels, and up-regulate IFN-γ levels. a-SMA is expressed at higher levels in epithelial cells and periductular collagen fibers during biliary atresia-induced hepatic fibrosis [29] , and its inhibition attenuates mouse lung fibrosis [30] Moreover, a hallmark of fibrosis is the accumulation of fibrillary collagens, especially collagen I. a-SMA and collagen I are widely used as indicators of fibrosis, including lung fibrosis [31] . Moreover, a hallmark of fibrosis is the accumulation of fibrillary collagens, especially collagen I. a-SMA and collagen I are widely used as indicators of fibrosis, including lung fibrosis [32] . The findings by Li et al. showed that TSLP over-expression significantly up-regulated a-SMA and collagen I levels, both of which were inhibited when TSLP was suppressed [33] . Airway remodeling is mainly due to Th2 lymphocyte cytokine-mediated immune responses [15, 34] . CD4 + Th2 cells produce an IL-4, IL-5 and IL-13 cytokine profile and have been shown to be important in the amplification and orchestration of asthma [35] . Additionally, the actions of TSLP in allergic inflammation are multifold, including the promotion of Th2 differentiation, either directly or indirectly, through dendritic cells (DCs) [36] . Hence, TSLP inhibition can down-regulate IL-4, IL-5 and IL-13 cytokines through CD4 + Th2 cells. IFN-γ blocks asthma development in young rhinovirus-infected mice [37] . As anti-TSLP can up-regulate IFN-γ, it is known that TSLP inhibition can alleviate asthma.
According to the correlation analysis results, WT m and WT t were positively related with the TSLP, OX40L, α-SMA and collagen-I levels. TSLP, OX40L, α-SMA and collagen-I play important roles in immune responses and airway inflammation. Additionally, these results could support the hypothesis that TSLP signaling pathway inhibition attenuates airway inflammation and remodeling in asthma. The TSLP signaling pathway regulates the Table 5 . TSLP, OX40L, IFN-γ, IL-4, IL-5 and IL-13 concentrations in the plasma detected by ELISA (ng/mL, n = 10). Note: TSLP, thymic stromal lymphopoietin; IL, interleukin; IFN, interferon; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; *, P < 0.05 compared with the control group; # , P < 0.05 compared with the asthma group; ▲, P < 0.05 compared with the IgG2a mAb group [18] . These findings provide further rational for the clinical use of available drug therapies in some clinical conditions. However, we can only reach limited conclusions from these findings. Even though signaling pathways may be affected by many factors, we still believe our findings may open a new avenue to understand the potential analgesic mechanisms of the TSLP signaling pathway on asthma airway inflammation and remodeling and to explore new effective approaches for preventing, minimizing, or completely relieving asthma. Further research studies are needed to confirm these findings and to define the relevant factors as well as other effects of the TSLP signaling pathway on airway inflammation and remodeling during asthma.
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